N/A
N=302
Cigarette and E-cigarette Flavors Manipulations in the Experimental Tobacco Marketplace
Tobacco Use Disorder
Bottom Line
View on ClinicalTrials.gov: NCT05110872 ↗Enrolled (actual)
302
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcome: Primary: Spent the Budget on E-cigarettes for Each Condition — 10.64; 14.87; 14.74; 14.65 percentage of spent budget
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Cigarette flavor restricted and e-cigarette flavor restricted (Behavioral); Cigarette flavor restricted and e-cigarette flavor unrestricted (Behavioral); Cigarette flavor unrestricted and e-cigarette flavor restricted (Behavioral); Cigarette flavor unrestricted and e-cigarette flavor unrestricted (Behavioral)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- Virginia Polytechnic Institute and State University
- Primary completion
- Aug 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Spent the Budget on E-cigarettes for Each Condition |
10.64; 14.87; 14.74; 14.65; 8.20; 15.03 | — |
| PRIMARY Spent Budget on Cigarettes for Each Condition |
55.04; 65.82; 53.05; 65.80; 73.60; 65.72 | — |
Summary
This is a one-session study that participants complete remotely including consent, Experimental Tobacco Marketplace purchases, and assessments to examine the effects of cigarette and e-cigarette flavors on cigarette demand and substitution in the Experimental Tobacco Marketplace.
Eligibility Criteria
Inclusion Criteria
- currently smoke at least 10 cigarettes per day
- have smoked at least 100 cigarettes (lifetime), and
- are 21 years of age or older.
Exclusion Criteria
- inaccurate identification of usual brand of cigarette's as menthol or non-menthol
Data sourced from ClinicalTrials.gov (NCT05110872). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.